nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—Amnesia—Methylprednisolone—ankylosing spondylitis	0.00442	0.00464	CcSEcCtD
Nelarabine—Speech disorder—Methotrexate—ankylosing spondylitis	0.0044	0.00462	CcSEcCtD
Nelarabine—Neuropathy—Prednisone—ankylosing spondylitis	0.00425	0.00446	CcSEcCtD
Nelarabine—DCK—Desoximetasone—Methylprednisolone—ankylosing spondylitis	0.00421	0.0885	CbGdCrCtD
Nelarabine—Hyperbilirubinaemia—Methotrexate—ankylosing spondylitis	0.00416	0.00437	CcSEcCtD
Nelarabine—Osteoarthritis—Triamcinolone—ankylosing spondylitis	0.00416	0.00436	CcSEcCtD
Nelarabine—Osteoarthritis—Methylprednisolone—ankylosing spondylitis	0.00415	0.00436	CcSEcCtD
Nelarabine—DCK—Desoximetasone—Dexamethasone—ankylosing spondylitis	0.00414	0.0871	CbGdCrCtD
Nelarabine—DCK—Desoximetasone—Betamethasone—ankylosing spondylitis	0.00414	0.0871	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Methylprednisolone—ankylosing spondylitis	0.00408	0.0859	CbGdCrCtD
Nelarabine—Hyperuricaemia—Methotrexate—ankylosing spondylitis	0.00408	0.00428	CcSEcCtD
Nelarabine—DCK—Desoximetasone—Triamcinolone—ankylosing spondylitis	0.00405	0.0851	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Dexamethasone—ankylosing spondylitis	0.00402	0.0846	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Betamethasone—ankylosing spondylitis	0.00402	0.0846	CbGdCrCtD
Nelarabine—Dysarthria—Methotrexate—ankylosing spondylitis	0.004	0.0042	CcSEcCtD
Nelarabine—Muscular weakness—Prednisolone—ankylosing spondylitis	0.00399	0.00419	CcSEcCtD
Nelarabine—Abdominal distension—Prednisolone—ankylosing spondylitis	0.00393	0.00413	CcSEcCtD
Nelarabine—Sepsis—Prednisone—ankylosing spondylitis	0.00393	0.00412	CcSEcCtD
Nelarabine—DCK—Diflorasone—Triamcinolone—ankylosing spondylitis	0.00393	0.0826	CbGdCrCtD
Nelarabine—Blood uric acid increased—Methotrexate—ankylosing spondylitis	0.00385	0.00404	CcSEcCtD
Nelarabine—Lethargy—Dexamethasone—ankylosing spondylitis	0.00385	0.00404	CcSEcCtD
Nelarabine—Lethargy—Betamethasone—ankylosing spondylitis	0.00385	0.00404	CcSEcCtD
Nelarabine—DCK—Desoximetasone—Prednisone—ankylosing spondylitis	0.00384	0.0808	CbGdCrCtD
Nelarabine—Osteoarthritis—Betamethasone—ankylosing spondylitis	0.00377	0.00396	CcSEcCtD
Nelarabine—Osteoarthritis—Dexamethasone—ankylosing spondylitis	0.00377	0.00396	CcSEcCtD
Nelarabine—DCK—Desoximetasone—Prednisolone—ankylosing spondylitis	0.00375	0.0789	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Prednisone—ankylosing spondylitis	0.00373	0.0784	CbGdCrCtD
Nelarabine—Muscular weakness—Triamcinolone—ankylosing spondylitis	0.00367	0.00385	CcSEcCtD
Nelarabine—Muscular weakness—Methylprednisolone—ankylosing spondylitis	0.00366	0.00384	CcSEcCtD
Nelarabine—Depressed level of consciousness—Methotrexate—ankylosing spondylitis	0.00365	0.00383	CcSEcCtD
Nelarabine—DCK—Diflorasone—Prednisolone—ankylosing spondylitis	0.00364	0.0765	CbGdCrCtD
Nelarabine—Abdominal distension—Triamcinolone—ankylosing spondylitis	0.00362	0.0038	CcSEcCtD
Nelarabine—Abdominal distension—Methylprednisolone—ankylosing spondylitis	0.00361	0.00379	CcSEcCtD
Nelarabine—Amnesia—Prednisone—ankylosing spondylitis	0.0035	0.00367	CcSEcCtD
Nelarabine—Coma—Methotrexate—ankylosing spondylitis	0.00346	0.00363	CcSEcCtD
Nelarabine—Hypokalaemia—Betamethasone—ankylosing spondylitis	0.00343	0.0036	CcSEcCtD
Nelarabine—Hypokalaemia—Dexamethasone—ankylosing spondylitis	0.00343	0.0036	CcSEcCtD
Nelarabine—Neoplasm—Methotrexate—ankylosing spondylitis	0.00342	0.00359	CcSEcCtD
Nelarabine—Neuropathy peripheral—Prednisolone—ankylosing spondylitis	0.00341	0.00359	CcSEcCtD
Nelarabine—Lethargy—Prednisone—ankylosing spondylitis	0.00335	0.00352	CcSEcCtD
Nelarabine—Muscular weakness—Betamethasone—ankylosing spondylitis	0.00333	0.00349	CcSEcCtD
Nelarabine—Muscular weakness—Dexamethasone—ankylosing spondylitis	0.00333	0.00349	CcSEcCtD
Nelarabine—Osteoarthritis—Prednisone—ankylosing spondylitis	0.00329	0.00345	CcSEcCtD
Nelarabine—Sepsis—Methotrexate—ankylosing spondylitis	0.00328	0.00345	CcSEcCtD
Nelarabine—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.0032	0.00336	CcSEcCtD
Nelarabine—Infestation—Methylprednisolone—ankylosing spondylitis	0.0032	0.00336	CcSEcCtD
Nelarabine—Neuropathy peripheral—Triamcinolone—ankylosing spondylitis	0.00314	0.0033	CcSEcCtD
Nelarabine—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	0.00313	0.00329	CcSEcCtD
Nelarabine—Epistaxis—Triamcinolone—ankylosing spondylitis	0.00302	0.00317	CcSEcCtD
Nelarabine—Hypokalaemia—Prednisone—ankylosing spondylitis	0.00299	0.00314	CcSEcCtD
Nelarabine—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.00294	0.00309	CcSEcCtD
Nelarabine—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.00294	0.00309	CcSEcCtD
Nelarabine—Muscular weakness—Prednisone—ankylosing spondylitis	0.0029	0.00304	CcSEcCtD
Nelarabine—Abdominal distension—Prednisone—ankylosing spondylitis	0.00286	0.003	CcSEcCtD
Nelarabine—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.00285	0.00299	CcSEcCtD
Nelarabine—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.00285	0.00299	CcSEcCtD
Nelarabine—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00282	0.00296	CcSEcCtD
Nelarabine—Lethargy—Methotrexate—ankylosing spondylitis	0.0028	0.00294	CcSEcCtD
Nelarabine—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.00275	0.00288	CcSEcCtD
Nelarabine—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00268	0.00282	CcSEcCtD
Nelarabine—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00266	0.0028	CcSEcCtD
Nelarabine—Neutropenia—Prednisone—ankylosing spondylitis	0.00265	0.00279	CcSEcCtD
Nelarabine—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.0026	0.00273	CcSEcCtD
Nelarabine—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00259	0.00272	CcSEcCtD
Nelarabine—Ataxia—Methotrexate—ankylosing spondylitis	0.00258	0.00271	CcSEcCtD
Nelarabine—Vision blurred—Prednisolone—ankylosing spondylitis	0.00257	0.00269	CcSEcCtD
Nelarabine—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00256	0.00269	CcSEcCtD
Nelarabine—Depression—Prednisone—ankylosing spondylitis	0.00252	0.00265	CcSEcCtD
Nelarabine—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00251	0.00264	CcSEcCtD
Nelarabine—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.0025	0.00262	CcSEcCtD
Nelarabine—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.00248	0.00261	CcSEcCtD
Nelarabine—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00245	0.00257	CcSEcCtD
Nelarabine—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00244	0.00256	CcSEcCtD
Nelarabine—Eye disorder—Betamethasone—ankylosing spondylitis	0.00244	0.00256	CcSEcCtD
Nelarabine—Back pain—Triamcinolone—ankylosing spondylitis	0.00242	0.00254	CcSEcCtD
Nelarabine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00239	0.00251	CcSEcCtD
Nelarabine—Angiopathy—Betamethasone—ankylosing spondylitis	0.00237	0.00249	CcSEcCtD
Nelarabine—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00237	0.00249	CcSEcCtD
Nelarabine—Convulsion—Prednisolone—ankylosing spondylitis	0.00236	0.00248	CcSEcCtD
Nelarabine—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00223	0.00234	CcSEcCtD
Nelarabine—Oedema—Prednisolone—ankylosing spondylitis	0.00222	0.00233	CcSEcCtD
Nelarabine—Neutropenia—Methotrexate—ankylosing spondylitis	0.00222	0.00233	CcSEcCtD
Nelarabine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.0022	0.00231	CcSEcCtD
Nelarabine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.0022	0.00231	CcSEcCtD
Nelarabine—Cough—Triamcinolone—ankylosing spondylitis	0.00218	0.00229	CcSEcCtD
Nelarabine—Convulsion—Triamcinolone—ankylosing spondylitis	0.00217	0.00228	CcSEcCtD
Nelarabine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00216	0.00227	CcSEcCtD
Nelarabine—Myalgia—Triamcinolone—ankylosing spondylitis	0.00213	0.00224	CcSEcCtD
Nelarabine—Pneumonia—Methotrexate—ankylosing spondylitis	0.00213	0.00223	CcSEcCtD
Nelarabine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00213	0.00223	CcSEcCtD
Nelarabine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00213	0.00223	CcSEcCtD
Nelarabine—Eye disorder—Prednisone—ankylosing spondylitis	0.00212	0.00223	CcSEcCtD
Nelarabine—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00212	0.00222	CcSEcCtD
Nelarabine—Infestation—Methotrexate—ankylosing spondylitis	0.00212	0.00222	CcSEcCtD
Nelarabine—Depression—Methotrexate—ankylosing spondylitis	0.00211	0.00221	CcSEcCtD
Nelarabine—Stomatitis—Methotrexate—ankylosing spondylitis	0.00206	0.00217	CcSEcCtD
Nelarabine—Angiopathy—Prednisone—ankylosing spondylitis	0.00206	0.00216	CcSEcCtD
Nelarabine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00206	0.00216	CcSEcCtD
Nelarabine—Oedema—Triamcinolone—ankylosing spondylitis	0.00204	0.00215	CcSEcCtD
Nelarabine—Infection—Triamcinolone—ankylosing spondylitis	0.00203	0.00213	CcSEcCtD
Nelarabine—Infection—Methylprednisolone—ankylosing spondylitis	0.00203	0.00213	CcSEcCtD
Nelarabine—Insomnia—Prednisolone—ankylosing spondylitis	0.00201	0.00211	CcSEcCtD
Nelarabine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.002	0.0021	CcSEcCtD
Nelarabine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.002	0.0021	CcSEcCtD
Nelarabine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.002	0.0021	CcSEcCtD
Nelarabine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.002	0.0021	CcSEcCtD
Nelarabine—Epistaxis—Methotrexate—ankylosing spondylitis	0.002	0.0021	CcSEcCtD
Nelarabine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.002	0.00209	CcSEcCtD
Nelarabine—Mental disorder—Prednisone—ankylosing spondylitis	0.00199	0.00209	CcSEcCtD
Nelarabine—Malnutrition—Prednisone—ankylosing spondylitis	0.00198	0.00208	CcSEcCtD
Nelarabine—Convulsion—Betamethasone—ankylosing spondylitis	0.00197	0.00207	CcSEcCtD
Nelarabine—Convulsion—Dexamethasone—ankylosing spondylitis	0.00197	0.00207	CcSEcCtD
Nelarabine—Myalgia—Betamethasone—ankylosing spondylitis	0.00193	0.00203	CcSEcCtD
Nelarabine—Myalgia—Dexamethasone—ankylosing spondylitis	0.00193	0.00203	CcSEcCtD
Nelarabine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00191	0.002	CcSEcCtD
Nelarabine—Pain—Prednisolone—ankylosing spondylitis	0.0019	0.00199	CcSEcCtD
Nelarabine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00188	0.00197	CcSEcCtD
Nelarabine—Vision blurred—Prednisone—ankylosing spondylitis	0.00186	0.00196	CcSEcCtD
Nelarabine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00186	0.00195	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00186	0.00195	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00186	0.00195	CcSEcCtD
Nelarabine—Oedema—Dexamethasone—ankylosing spondylitis	0.00185	0.00195	CcSEcCtD
Nelarabine—Oedema—Betamethasone—ankylosing spondylitis	0.00185	0.00195	CcSEcCtD
Nelarabine—Insomnia—Triamcinolone—ankylosing spondylitis	0.00185	0.00194	CcSEcCtD
Nelarabine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00184	0.00194	CcSEcCtD
Nelarabine—Infection—Betamethasone—ankylosing spondylitis	0.00184	0.00193	CcSEcCtD
Nelarabine—Infection—Dexamethasone—ankylosing spondylitis	0.00184	0.00193	CcSEcCtD
Nelarabine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00183	0.00193	CcSEcCtD
Nelarabine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00183	0.00192	CcSEcCtD
Nelarabine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00183	0.00192	CcSEcCtD
Nelarabine—Anaemia—Prednisone—ankylosing spondylitis	0.00183	0.00192	CcSEcCtD
Nelarabine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00182	0.00191	CcSEcCtD
Nelarabine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00182	0.00191	CcSEcCtD
Nelarabine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00182	0.00191	CcSEcCtD
Nelarabine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00182	0.00191	CcSEcCtD
Nelarabine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00182	0.00191	CcSEcCtD
Nelarabine—Eye disorder—Methotrexate—ankylosing spondylitis	0.00177	0.00186	CcSEcCtD
Nelarabine—Anorexia—Dexamethasone—ankylosing spondylitis	0.00177	0.00186	CcSEcCtD
Nelarabine—Anorexia—Betamethasone—ankylosing spondylitis	0.00177	0.00186	CcSEcCtD
Nelarabine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00176	0.00185	CcSEcCtD
Nelarabine—Fatigue—Triamcinolone—ankylosing spondylitis	0.00176	0.00185	CcSEcCtD
Nelarabine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00176	0.00185	CcSEcCtD
Nelarabine—Pain—Triamcinolone—ankylosing spondylitis	0.00175	0.00183	CcSEcCtD
Nelarabine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00174	0.00183	CcSEcCtD
Nelarabine—Hypotension—Dexamethasone—ankylosing spondylitis	0.00173	0.00182	CcSEcCtD
Nelarabine—Hypotension—Betamethasone—ankylosing spondylitis	0.00173	0.00182	CcSEcCtD
Nelarabine—Angiopathy—Methotrexate—ankylosing spondylitis	0.00172	0.00181	CcSEcCtD
Nelarabine—Convulsion—Prednisone—ankylosing spondylitis	0.00171	0.0018	CcSEcCtD
Nelarabine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00171	0.0018	CcSEcCtD
Nelarabine—Chills—Methotrexate—ankylosing spondylitis	0.0017	0.00179	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00169	0.00177	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00169	0.00177	CcSEcCtD
Nelarabine—Arthralgia—Prednisone—ankylosing spondylitis	0.00168	0.00177	CcSEcCtD
Nelarabine—Myalgia—Prednisone—ankylosing spondylitis	0.00168	0.00177	CcSEcCtD
Nelarabine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00168	0.00177	CcSEcCtD
Nelarabine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00168	0.00176	CcSEcCtD
Nelarabine—Insomnia—Dexamethasone—ankylosing spondylitis	0.00168	0.00176	CcSEcCtD
Nelarabine—Insomnia—Betamethasone—ankylosing spondylitis	0.00168	0.00176	CcSEcCtD
Nelarabine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00167	0.00175	CcSEcCtD
Nelarabine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00166	0.00175	CcSEcCtD
Nelarabine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00166	0.00175	CcSEcCtD
Nelarabine—Mental disorder—Methotrexate—ankylosing spondylitis	0.00166	0.00175	CcSEcCtD
Nelarabine—Malnutrition—Methotrexate—ankylosing spondylitis	0.00165	0.00174	CcSEcCtD
Nelarabine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00162	0.0017	CcSEcCtD
Nelarabine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00162	0.0017	CcSEcCtD
Nelarabine—Oedema—Prednisone—ankylosing spondylitis	0.00161	0.0017	CcSEcCtD
Nelarabine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00161	0.00169	CcSEcCtD
Nelarabine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00161	0.00169	CcSEcCtD
Nelarabine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00161	0.00169	CcSEcCtD
Nelarabine—Infection—Prednisone—ankylosing spondylitis	0.0016	0.00168	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.0016	0.00168	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.0016	0.00168	CcSEcCtD
Nelarabine—Back pain—Methotrexate—ankylosing spondylitis	0.0016	0.00168	CcSEcCtD
Nelarabine—Fatigue—Betamethasone—ankylosing spondylitis	0.0016	0.00168	CcSEcCtD
Nelarabine—Fatigue—Dexamethasone—ankylosing spondylitis	0.0016	0.00168	CcSEcCtD
Nelarabine—Pain—Betamethasone—ankylosing spondylitis	0.00159	0.00166	CcSEcCtD
Nelarabine—Pain—Dexamethasone—ankylosing spondylitis	0.00159	0.00166	CcSEcCtD
Nelarabine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00158	0.00166	CcSEcCtD
Nelarabine—Vision blurred—Methotrexate—ankylosing spondylitis	0.00156	0.00164	CcSEcCtD
Nelarabine—Anorexia—Prednisone—ankylosing spondylitis	0.00154	0.00162	CcSEcCtD
Nelarabine—Anaemia—Methotrexate—ankylosing spondylitis	0.00153	0.0016	CcSEcCtD
Nelarabine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00153	0.0016	CcSEcCtD
Nelarabine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00153	0.0016	CcSEcCtD
Nelarabine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00152	0.00159	CcSEcCtD
Nelarabine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00152	0.00159	CcSEcCtD
Nelarabine—Leukopenia—Methotrexate—ankylosing spondylitis	0.00148	0.00155	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00147	0.00154	CcSEcCtD
Nelarabine—Dizziness—Prednisolone—ankylosing spondylitis	0.00147	0.00154	CcSEcCtD
Nelarabine—Asthenia—Triamcinolone—ankylosing spondylitis	0.00147	0.00154	CcSEcCtD
Nelarabine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00147	0.00154	CcSEcCtD
Nelarabine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00147	0.00154	CcSEcCtD
Nelarabine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00147	0.00154	CcSEcCtD
Nelarabine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00147	0.00154	CcSEcCtD
Nelarabine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00146	0.00154	CcSEcCtD
Nelarabine—Insomnia—Prednisone—ankylosing spondylitis	0.00146	0.00153	CcSEcCtD
Nelarabine—Paraesthesia—Prednisone—ankylosing spondylitis	0.00145	0.00152	CcSEcCtD
Nelarabine—Cough—Methotrexate—ankylosing spondylitis	0.00144	0.00151	CcSEcCtD
Nelarabine—Convulsion—Methotrexate—ankylosing spondylitis	0.00143	0.0015	CcSEcCtD
Nelarabine—Chest pain—Methotrexate—ankylosing spondylitis	0.00141	0.00148	CcSEcCtD
Nelarabine—Arthralgia—Methotrexate—ankylosing spondylitis	0.00141	0.00148	CcSEcCtD
Nelarabine—Myalgia—Methotrexate—ankylosing spondylitis	0.00141	0.00148	CcSEcCtD
Nelarabine—Decreased appetite—Prednisone—ankylosing spondylitis	0.0014	0.00147	CcSEcCtD
Nelarabine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00139	0.00146	CcSEcCtD
Nelarabine—Fatigue—Prednisone—ankylosing spondylitis	0.00139	0.00146	CcSEcCtD
Nelarabine—Headache—Prednisolone—ankylosing spondylitis	0.00139	0.00146	CcSEcCtD
Nelarabine—Constipation—Prednisone—ankylosing spondylitis	0.00138	0.00145	CcSEcCtD
Nelarabine—Confusional state—Methotrexate—ankylosing spondylitis	0.00136	0.00143	CcSEcCtD
Nelarabine—Dizziness—Triamcinolone—ankylosing spondylitis	0.00135	0.00142	CcSEcCtD
Nelarabine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00135	0.00142	CcSEcCtD
Nelarabine—Infection—Methotrexate—ankylosing spondylitis	0.00134	0.00141	CcSEcCtD
Nelarabine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00133	0.0014	CcSEcCtD
Nelarabine—Asthenia—Betamethasone—ankylosing spondylitis	0.00133	0.0014	CcSEcCtD
Nelarabine—Asthenia—Dexamethasone—ankylosing spondylitis	0.00133	0.0014	CcSEcCtD
Nelarabine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00132	0.00139	CcSEcCtD
Nelarabine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00132	0.00139	CcSEcCtD
Nelarabine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00132	0.00139	CcSEcCtD
Nelarabine—Nausea—Prednisolone—ankylosing spondylitis	0.00132	0.00139	CcSEcCtD
Nelarabine—Vomiting—Triamcinolone—ankylosing spondylitis	0.0013	0.00136	CcSEcCtD
Nelarabine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.0013	0.00136	CcSEcCtD
Nelarabine—Anorexia—Methotrexate—ankylosing spondylitis	0.00129	0.00135	CcSEcCtD
Nelarabine—Headache—Triamcinolone—ankylosing spondylitis	0.00128	0.00134	CcSEcCtD
Nelarabine—Headache—Methylprednisolone—ankylosing spondylitis	0.00128	0.00134	CcSEcCtD
Nelarabine—Abdominal pain—Prednisone—ankylosing spondylitis	0.00128	0.00134	CcSEcCtD
Nelarabine—Body temperature increased—Prednisone—ankylosing spondylitis	0.00128	0.00134	CcSEcCtD
Nelarabine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00127	0.00133	CcSEcCtD
Nelarabine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00127	0.00133	CcSEcCtD
Nelarabine—Hypotension—Methotrexate—ankylosing spondylitis	0.00126	0.00132	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00123	0.00129	CcSEcCtD
Nelarabine—Dizziness—Dexamethasone—ankylosing spondylitis	0.00123	0.00129	CcSEcCtD
Nelarabine—Dizziness—Betamethasone—ankylosing spondylitis	0.00123	0.00129	CcSEcCtD
Nelarabine—Insomnia—Methotrexate—ankylosing spondylitis	0.00122	0.00128	CcSEcCtD
Nelarabine—Nausea—Triamcinolone—ankylosing spondylitis	0.00121	0.00127	CcSEcCtD
Nelarabine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00121	0.00127	CcSEcCtD
Nelarabine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00121	0.00127	CcSEcCtD
Nelarabine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.0012	0.00126	CcSEcCtD
Nelarabine—Somnolence—Methotrexate—ankylosing spondylitis	0.0012	0.00126	CcSEcCtD
Nelarabine—Vomiting—Dexamethasone—ankylosing spondylitis	0.00118	0.00124	CcSEcCtD
Nelarabine—Vomiting—Betamethasone—ankylosing spondylitis	0.00118	0.00124	CcSEcCtD
Nelarabine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00117	0.00123	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00116	0.00122	CcSEcCtD
Nelarabine—Fatigue—Methotrexate—ankylosing spondylitis	0.00116	0.00122	CcSEcCtD
Nelarabine—Headache—Betamethasone—ankylosing spondylitis	0.00116	0.00122	CcSEcCtD
Nelarabine—Headache—Dexamethasone—ankylosing spondylitis	0.00116	0.00122	CcSEcCtD
Nelarabine—Asthenia—Prednisone—ankylosing spondylitis	0.00116	0.00122	CcSEcCtD
Nelarabine—Pain—Methotrexate—ankylosing spondylitis	0.00115	0.00121	CcSEcCtD
Nelarabine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00111	0.00117	CcSEcCtD
Nelarabine—Diarrhoea—Prednisone—ankylosing spondylitis	0.0011	0.00116	CcSEcCtD
Nelarabine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.0011	0.00116	CcSEcCtD
Nelarabine—Nausea—Betamethasone—ankylosing spondylitis	0.0011	0.00116	CcSEcCtD
Nelarabine—Nausea—Dexamethasone—ankylosing spondylitis	0.0011	0.00116	CcSEcCtD
Nelarabine—Dizziness—Prednisone—ankylosing spondylitis	0.00107	0.00112	CcSEcCtD
Nelarabine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00107	0.00112	CcSEcCtD
Nelarabine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00107	0.00112	CcSEcCtD
Nelarabine—Vomiting—Prednisone—ankylosing spondylitis	0.00103	0.00108	CcSEcCtD
Nelarabine—Headache—Prednisone—ankylosing spondylitis	0.00101	0.00106	CcSEcCtD
Nelarabine—Asthenia—Methotrexate—ankylosing spondylitis	0.000968	0.00102	CcSEcCtD
Nelarabine—Nausea—Prednisone—ankylosing spondylitis	0.000959	0.00101	CcSEcCtD
Nelarabine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000923	0.000969	CcSEcCtD
Nelarabine—Dizziness—Methotrexate—ankylosing spondylitis	0.000892	0.000937	CcSEcCtD
Nelarabine—Vomiting—Methotrexate—ankylosing spondylitis	0.000858	0.000901	CcSEcCtD
Nelarabine—Headache—Methotrexate—ankylosing spondylitis	0.000845	0.000888	CcSEcCtD
Nelarabine—Nausea—Methotrexate—ankylosing spondylitis	0.000802	0.000841	CcSEcCtD
